News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Independent report vindicates Salamol decision

January 2006

Independent report vindicates Salamol decision

A report by Government medicines assessment agency Medsafe has confirmed that the Salamol brand of salbutamol asthma inhalers is safe and effective.

Medsafe commissioned tests after a number of complaints were received about the Salamol inhalers, which were introduced from February 2005.

Testing carried out by ESR in New Zealand and TGAL in Australia found that Salamol inhalers delivered the correct dosage in line with the product specifications, and that regular cleaning, as specified in the instructions for all CFC-free inhalers, could avert clogging.

The report concludes: "Following investigation and testing Medsafe was satisfied that Salamol met the international requirements and guidelines for quality, safety and efficacy required for a medicine registered and distributed in New Zealand."[1]

PHARMAC Medical Director Dr Peter Moodie says the report reinforces the initial view that Salamol inhalers are just as safe and effective for New Zealanders with asthma as Ventolin inhalers.

"The findings of this report are reassuring," Dr Moodie says. "We did have concerns raised with us earlier this year and felt it was wise to work with Medsafe to have those concerns addressed.

"The findings show that both patients and prescribers can have confidence in the effectiveness of Salamol, and that there are no clinical issues for people changing from Ventolin to Salamol."

Pending the outcome of testing, PHARMAC agreed to continue to subsidise Ventolin inhalers at the same level as Salamol. Ventolin inhalers incur a manufacturer's surcharge, and will continue to be funded until at least 2007.

Salamol has steadily gained acceptance in New Zealand and now accounts for up to 30% of all salbutamol inhalers dispensed.

  • Full report is available at

  • ENDS

    © Scoop Media

    Culture Headlines | Health Headlines | Education Headlines


    Howard Davis: Review - A Girl Named Mo

    Moana Ete brought her three-piece band A Girl Named Mo to Wellington's intimate and iconic Bats Theatre last week for a five-night residency. Each show was recorded and filmed live for the release of her debut album 'Platonic/Romantic' on Loop records later this year. More>>

    For The Birds: Who Will Be Crowned Bird Of The Year?

    The competition involves well-known and enthusiastic New Zealanders acting as ‘campaign managers’ for their favourite birds with many going to great lengths to get New Zealanders to vote for their chosen bird... More>>


  • Greening the Red Zone - Bird of the year heats up: kōtare concedes, backs kea
  • Image Out-Link - Giselle Clarkson on Twitter
  • Gordon Campbell: On Bob Dylan's Nobel (And The Surplus)

    So Bob Dylan has just won the Nobel Prize for… Literature? Wow. I’d be just as happy if he’d won for his work on particle physics (“One Grain of Sand”, “Simple Twist of Fate”) or got the Economics prize for his work on the theory of contracting (“Don’t Think Twice Its Alright”) ... More>>


    Scoop Review Of Books: Whose Goat Was That?

    Mysterious Mysteries of Aro Valley is a sharp, satirical and sometimes downright scary romp through and around that valley in ways that made me question the realities of the places I thought I knew so well. More>>


    NZ On Air TV Funding: More Comedy Comes Out Of The Shadows

    Paranormal Event Response Unit is a series conceived by Jemaine Clement and Taika Waititi as a TV spin-off from their highly acclaimed feature film What We Do In The Shadows. More>>


    Mars News: Winners Announced For The 2016 Apra Silver Scroll Awards

    Wellington singer-songwriter and internationally acclaimed musician Thomas Oliver has won the 2016 APRA Silver Scroll Award with his captivating love song ‘If I Move To Mars’. More>>


    Get More From Scoop



    Search Scoop  
    Powered by Vodafone
    NZ independent news